Questions for May 20 Presentation - Bibliography

Thanks for visiting!

To translate this page, select your

language from the dropdown menu below:


Depending on when you visited, the following may still be incomplete.

For those who use Zotero, information has also been shared via 

Group Name: "Long COVID - May 20"



A free version of Zotero is available for download at this link.


Question numbering below serves only to facilitate sorting in our Bibliography, using Zotero.

Specific Questions that were asked, will be referred to here as well. To get a feel for all of that, just have a look below ...




  1. Overview or Summary data for "long-term" COVID (LTC)

Akbarialiabad, Hossein, Mohammad Hossein Taghrir, Ashkan Abdollahi, Nasrollah Ghahramani, Manasi Kumar, Shahram Paydar, Babak Razani, et al. Long COVID, a Comprehensive Systematic Scoping Review, 2021.
Cirulli, Elizabeth, Kelly Barrett, Stephen Riffle, Alexandre Bolze, Iva Neveux, Shaun Dabe, Joseph Grzymski, James Lu, and Nicole Washington. Long-Term COVID-19 Symptoms in a Large Unselected Population, 2020.
“COVID ‘Long Haulers’: Long-Term Effects of COVID-19.” Accessed April 24, 2022.
Davis, Hannah, Gina Assaf, Lisa McCorkell, Hannah Wei, Ryan Low, Yochai Re’em, Signe Redfield, Jared Austin, and Athena Akrami. “Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact.” EClinicalMedicine 38 (July 1, 2021): 101019.
Dept of Homeland Security. “Master Question List for COVID-19 (Caused by SARS-CoV-2),” n.d., 97.
Jin, Hongxia, Lu Lu, and Haojun Fan. “Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis.” International Journal of Environmental Research and Public Health 19, no. 6 (January 2022): 3742.
———. “Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis.” International Journal of Environmental Research and Public Health 19 (March 21, 2022).
Larkin, Howard D. “Global COVID-19 Death Toll May Be Triple the Reported Deaths.” JAMA 327, no. 15 (April 19, 2022): 1438.
“Master Question List | Homeland Security.” Accessed April 22, 2022.
Michelen, Melina, Lakshmi Manoharan, Natalie Elkheir, Vincent Cheng, Andrew Dagens, Claire Hastie, Margaret O’Hara, et al. “Characterising Long COVID: A Living Systematic Review.” BMJ Global Health 6 (September 1, 2021): e005427.
Nalbandian, Ani, Kartik Sehgal, Aakriti Gupta, Mahesh V. Madhavan, Claire McGroder, Jacob S. Stevens, Joshua R. Cook, et al. “Post-Acute COVID-19 Syndrome.” Nature Medicine 27, no. 4 (April 2021): 601–15.
Nurek, Martine, Clare Rayner, Anette Freyer, Sharon Taylor, Linn Järte, Nathalie MacDermott, and Brendan C Delaney. “Recommendations for the Recognition, Diagnosis, and Management of Long COVID: A Delphi Study.” British Journal of General Practice 71, no. 712 (November 2021): e815–25.
Sigfrid, Louise, Thomas Drake, Ellen Pauley, Edwin Jesudason, Piero Olliaro, Wei Shen Lim, Annelies Gillesen, et al. “Long Covid in Adults Discharged from UK Hospitals after Covid-19: A Prospective, Multicentre Cohort Study Using the ISARIC WHO Clinical Characterisation Protocol.” The Lancet Regional Health. Europe 8 (August 6, 2021): 100186.
Sudre, Carole, Benjamin Murray, Thomas Varsavsky, Mark Graham, Rose Penfold, Ruth Bowyer, Joan Pujol, et al. Attributes and Predictors of Long-COVID: Analysis of COVID Cases and Their Symptoms Collected by the Covid Symptoms Study App, 2020.

2. Susceptibility to or Risk Factors for LTC

2a. Hypertension & Diabetes


Fernández-de-Las-Peñas, César, Carlos Guijarro Herraiz, Juan torres-macho, María Velasco, Plaza-Canteli Susana, Valentín Hernandez-Barrera, and José Arias-Navalón. “Diabetes and the Risk of Long-Term Post-COVID Symptoms.” Diabetes 70 (September 27, 2021): db210329.
Scherer, Philipp, John Kirwan, and Clifford Rosen. “Post-Acute Sequelae of COVID-19: A Metabolic Perspective.” ELife 11 (March 23, 2022).
Tadic, Marijana, and Cesare Cuspidi. “The Influence of Diabetes and Hypertension on Outcome in COVID‐19 Patients: Do We Mix Apples and Oranges?” The Journal of Clinical Hypertension 23, no. 2 (February 2021): 235–37.



2b. Down's Syndrome


Clift, Ashley Kieran, Carol A.C. Coupland, Ruth H. Keogh, Harry Hemingway, and Julia Hippisley-Cox. “COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.” Annals of Internal Medicine 174, no. 4 (April 2021): 572–76.
———. “COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.” Annals of Internal Medicine 174, no. 4 (April 2021): 572–76.
De Toma, Ilario, and Mara Dierssen. “Network Analysis of Down Syndrome and SARS-CoV-2 Identifies Risk and Protective Factors for COVID-19.” Scientific Reports 11, no. 1 (December 2021): 1930.


2c. Nutrition and LTC susceptibility


Butler, Michael, and Ruth Barrientos. “The Impact of Nutrition on COVID-19 Susceptibility and Long-Term Consequences.” Brain, Behavior, and Immunity 87 (April 1, 2020).



2d. Genetic susceptibility
SeyedAlinaghi, SeyedAhmad, Mohammad Mehrtak, Mehrzad MohsseniPour, Pegah Mirzapour, Alireza Barzegary, Pedram Habibi, Banafsheh Moradmand-Badie, et al. “Genetic Susceptibility of COVID-19: A Systematic Review of Current Evidence.” European Journal of Medical Research 26, no. 1 (December 2021): 46.



2e. Female predominance


Fernández-de-las-Peñas, César, José D. Martín-Guerrero, Óscar J. Pellicer-Valero, Esperanza Navarro-Pardo, Víctor Gómez-Mayordomo, María L. Cuadrado, José A. Arias-Navalón, Margarita Cigarán-Méndez, Valentín Hernández-Barrera, and Lars Arendt-Nielsen. “Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study.” Journal of Clinical Medicine 11, no. 2 (January 14, 2022): 413.
Gebhard, Caroline E., Claudia Sütsch, Susan Bengs, Manja Deforth, Karl Philipp Buehler, Nadia Hamouda, Alexander Meisel, et al. “Sex- and Gender-Specific Risk Factors of Post-COVID-19 Syndrome: A Population-Based Cohort Study in Switzerland.” Preprint. Infectious Diseases (except HIV/AIDS), July 6, 2021.



2f. Acute findings predicting LTC


Apple, Alexandra C., Alexis Oddi, Michael J. Peluso, Breton M. Asken, Timothy J. Henrich, J. Daniel Kelly, Samuel J. Pleasure, et al. “Risk Factors and Abnormal Cerebrospinal Fluid Associate with Cognitive Symptoms after Mild COVID ‐19.” Annals of Clinical and Translational Neurology 9, no. 2 (February 2022): 221–26.
Chen, Chen, Spencer R. Haupert, Lauren Zimmermann, Xu Shi, Lars G. Fritsche, and Bhramar Mukherjee. “Global Prevalence of Post-Acute Sequelae of COVID-19 (PASC) or Long COVID: A Meta-Analysis and Systematic Review.” Preprint. Epidemiology, November 16, 2021.
Moreno-Pérez, Oscar, Esperanza Merino, Jose-Manuel Leon-Ramirez, Mariano Andres, Jose Manuel Ramos, Juan Arenas-Jiménez, Santos Asensio, et al. “Post-Acute COVID-19 Syndrome. Incidence and Risk Factors: A Mediterranean Cohort Study.” Journal of Infection 82, no. 3 (March 2021): 378–83.
2g. BAME and Acute COVID


Abuelgasim, Eyad, Li Jing Saw, Manasi Shirke, Mohamed Zeinah, and Amer Harky. “COVID-19: Unique Public Health Issues Facing Black, Asian and Minority Ethnic Communities.” Current Problems in Cardiology 45, no. 8 (August 2020): 100621.
Amram, Ofer, Jeanne Robison, Solmaz Amiri, Bethann Pflugeisen, John Roll, and Pablo Monsivais. “Socioeconomic and Racial Inequities in Breast Cancer Screening During the COVID-19 Pandemic in Washington State.” JAMA Network Open 4, no. 5 (May 24, 2021): e2110946.
Andrist, Erica, Mark Nuppnau, Ryan P. Barbaro, Thomas S. Valley, and Michael W. Sjoding. “Association of Race With Pulse Oximetry Accuracy in Hospitalized Children.” JAMA Network Open 5, no. 3 (March 31, 2022): e224584.
Cooper, Lisa A., and David R. Williams. “Excess Deaths From COVID-19, Community Bereavement, and Restorative Justice for Communities of Color.” JAMA 324, no. 15 (October 20, 2020): 1491.
“Disparities in the Risk and Outcomes of COVID-19,” n.d., 92.
Dryden-Peterson, Scott, Gustavo E. Velásquez, Thomas J. Stopka, Sonya Davey, Shahin Lockman, and Bisola O. Ojikutu. “Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic.” JAMA Network Open 4, no. 2 (February 9, 2021): e2037067.
Feldman, Justin M., and Mary T. Bassett. “Variation in COVID-19 Mortality in the US by Race and Ethnicity and Educational Attainment.” JAMA Network Open 4, no. 11 (November 23, 2021): e2135967.
Fu, Julie, Sonya A. Reid, Benjamin French, Cassandra Hennessy, Clara Hwang, Na Tosha Gatson, Narjust Duma, et al. “Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.” JAMA Network Open 5, no. 3 (March 28, 2022): e224304.
Galea, Sandro. “Reckoning With COVID-19 Exceptionalism.” JAMA Health Forum 2, no. 12 (December 9, 2021): e214854.
Lopez, Leo, Louis H. Hart, and Mitchell H. Katz. “Racial and Ethnic Health Disparities Related to COVID-19.” JAMA 325, no. 8 (February 23, 2021): 719.
Mah, Jasmine C., and Melissa K. Andrew. “Social Vulnerability Indices: A Pragmatic Tool for COVID-19 Policy and Beyond.” The Lancet Regional Health - Europe 14 (March 2022): 100333.
Mody, Aaloke, Kristin Pfeifauf, and Elvin H. Geng. “Using Lorenz Curves to Measure Racial Inequities in COVID-19 Testing.” JAMA Network Open 4, no. 1 (January 8, 2021): e2032696.
Musshafen, Leslie A., Lamees El-Sadek, Seth T. Lirette, Richard L. Summers, Caroline Compretta, and Thomas E. Dobbs. “In-Hospital Mortality Disparities Among American Indian and Alaska Native, Black, and White Patients With COVID-19.” JAMA Network Open 5, no. 3 (March 30, 2022): e224822.
Sacarny, Adam, and Jamie R. Daw. “Inequities in COVID-19 Vaccination Rates in the 9 Largest US Cities.” JAMA Health Forum 2, no. 9 (September 3, 2021): e212415.
2g1. BAME & Long COVID (LTC) “Long Covid Impact on Black, Asian and Minority Ethnic Healthcare Workers to Be Examined,” December 11, 2021.
Nalbandian, Ani, Kartik Sehgal, Aakriti Gupta, Mahesh V. Madhavan, Claire McGroder, Jacob S. Stevens, Joshua R. Cook, et al. “Post-Acute COVID-19 Syndrome.” Nature Medicine 27, no. 4 (April 2021): 601–15.
Pareek, Manish, Mansoor N Bangash, Nilesh Pareek, Daniel Pan, Shirley Sze, Jatinder S Minhas, Wasim Hanif, and Kamlesh Khunti. “Ethnicity and COVID-19: An Urgent Public Health Research Priority.” The Lancet 395, no. 10234 (May 2020): 1421–22.
STAT. “Researchers Fear People of Color May Be Disproportionately Affected by Long Covid,” May 10, 2021.

3. Pediatrics and LTC

STAT. “As More Kids Go down the ‘Deep, Dark Tunnel’ of Long Covid, Doctors Still Can’t Predict Who Is at Risk,” June 10, 2021.
Brackel, Caroline, Coen Lap, Emmeline Buddingh, Marlies Houten, Linda van der Sande, Eveline Langereis, Michiel Bannier, Marielle Pijnenburg, Simone Hashimoto, and Suzanne Terheggen-Lagro. “Pediatric Long-COVID: An Overlooked Phenomenon?” Pediatric Pulmonology 56 (June 8, 2021).
Buonsenso, Danilo, Daniel Munblit, Cristina De Rose, Dario Sinatti, Antonia Ricchiuto, Angelo Carfi, and Piero Valentini. “Preliminary Evidence on Long COVID in Children.” Acta Paediatrica 110, no. 7 (July 2021): 2208–11.
Fainardi, Valentina, Aniello Meoli, Giulia Chiopris, Matteo Motta, Kaltra Skenderaj, Roberto Grandinetti, Andrea Bergomi, Francesco Antodaro, Stefano Zona, and Susanna Esposito. “Long COVID in Children and Adolescents.” Life 12 (February 14, 2022): 285.
———. “Long COVID in Children and Adolescents.” Life 12 (February 14, 2022): 285.
Thallapureddy, Keerthi, Khyathi Thallapureddy, Erika Zerda, Neeraj Suresh, Deepak Kamat, Karthik Rajasekaran, and Alvaro Moreira. “Long-Term Complications of COVID-19 Infection in Adolescents and Children.” Current Pediatrics Reports 10 (March 1, 2022): 3.

4. (Reserved Space)


5. Matching LTC to other illnesses

Sukocheva, Olga A., Rebekah Maksoud, Narasimha M. Beeraka, SabbaRao V. Madhunapantula, Mikhail Sinelnikov, Vladimir N. Nikolenko, Margarita E. Neganova, et al. “Analysis of Post COVID-19 Condition and Its Overlap with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.” Journal of Advanced Research, November 26, 2021.

6. Therapeutic Approach

6a. Barrier Measures (Prevention)


Wang, X.; Pan, Y.; Zhang, D.; Chen, L.; Jia, L.; Li, X.; Yang, P.; Wang, Q.; Macintyre, C. R., Basic epidemiological parameter values from data of real-world in mega-cities: the characteristics of COVID-19 in Beijing, China. BMC Infectious Diseases 2020, 20 (1), 526.


Rickman, H. M.; Rampling, T.; Shaw, K.; Martinez-Garcia, G.; Hail, L.; Coen, P.; Shahmanesh, M.; Shin, G. Y.; Nastouli, E.; Houlihan, C. F., Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital. Clinical Infectious Diseases 2020.


Wang, X.; Ferro, E. G.; Zhou, G.; Hashimoto, D.; Bhatt, D. L., Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers. JAMA 2020.


Zhu, S.; Zong, Z., Why did so few healthcare workers in China get COVID-19 infection. QJM: An International Journal of Medicine 2020



Jones, R. M., Relative contributions of transmission routes for COVID-19 among healthcare personnel providing patient care. Journal of Occupational and Environmental Hygiene 2020, 1-8.


WHO, Mask use in the context of COVID-19; World Health Organization: 1 December 2020, 2020.


WHO, Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected; 2020.


Weissman, D. N.; de Perio, M. A.; Radonovich, L. J., Jr, COVID-19 and Risks Posed to Personnel During Endotracheal Intubation. JAMA 2020.


Feldman, O.; Meir, M.; Shavit, D.; Idelman, R.; Shavit, I., Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment. JAMA 2020.


WHO, Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases.


Klompas, M.; Baker, M.; Rhee, C., What Is an Aerosol-Generating Procedure? JAMA Surgery 2021, 156 (2), 113-114.


Brosseau, L. M.; Jones, R., Commentary: Protecting health workers from airborne MERS-CoV learning from SARS.


FDA, FAQs on Shortages of Surgical Masks and Gowns.


FDA, Respirator Models Removed from Appendix A. (accessed 05/15/2020).


Zha, M.; Alsarraj, J.; Bunch, B.; Venzon, D., Impact on the fitness of N95 masks with extended use/limited reuse and dry heat decontamination. Journal of Investigative Medicine 2021, jim-2021001908.


Degesys, N. F.; Wang, R. C.; Kwan, E.; Fahimi, J.; Noble, J. A.; Raven, M. C., Correlation Between N95 Extended Use and Reuse and Fit Failure in an Emergency Department. JAMA 2020.


Byambasuren, O.; Beller, E.; Clark, J.; Collignon, P.; Glasziou, P., The effect of eye protection on SARS-CoV-2 transmission: a systematic review. Antimicrobial Resistance & Infection Control 2021, 10 (1), 156.


Cheng, Y.; Ma, N.; Witt, C.; Rapp, S.; Wild, P. S.; Andreae, M. O.; Pöschl, U.; Su, H., Face masks effectively limit the probability of SARS-CoV-2 transmission. Science 2021, eabg6296.


Fawcett, S. E.; Madhusudhan, M. S.; Gaddam, E. N.; Almario, M. J.; Masih, S. R.; Klute-Evans, D. D.; Johnson, J. C.; Stroud, C. D.; Dolan-Caren, J. A.; Ben-Aderet, M. A.; Luria, J.; Morgan, M. A.; Vail, E.; Grein, J. D., Transmission risk of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) to healthcare personnel following unanticipated exposure to aerosol-generating procedures: Experience from epidemiologic investigations at an academic medical center. Infection Control & Hospital Epidemiology 2021, 1-3.


Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings. Annals of Internal Medicine 0 (0), null.



6b. Vaccination (Prevention)
6b1. the Vaccines


Yale Medicine. “Comparing the COVID-19 Vaccines: How Are They Different?” Accessed April 12, 2022.
Healthline. “What You Need To Know About AstraZeneca vs Pfizer Vaccine,” August 22, 2021.
6b1.1 Vaccination and LT COVID


6b1.2 Breakthrough COVID and LTC
Al-Aly, Ziyad, Benjamin Bowe, and Yan Xie. “Long Covid after Breakthrough COVID-19: The Post-Acute Sequelae of Breakthrough COVID-19.” Preprint. In Review, November 15, 2021.
6b2. the Vaccine Concerns
“In Rare Cases, Coronavirus Vaccines May Cause Long Covid–like Symptoms.” Accessed April 12, 2022.
Seneff, Stephanie, and Greg Nigh. “Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the MRNA Vaccines Against COVID-19,” n.d., 42.
Seneff, Stephanie, Greg Nigh, Anthony M. Kyriakopoulos, and Peter A McCullough. “Innate Immune Suppression by SARS-CoV-2 MRNA Vaccinations: The Role of G-Quadruplexes, Exosomes and MicroRNAs.” Preprint. Preprints, January 21, 2022.
———. “Innate Immune Suppression by SARS-CoV-2 MRNA Vaccinations: The Role of G-Quadruplexes, Exosomes and MicroRNAs.” Preprint. Preprints, January 21, 2022.
Wisnivesky, Juan P., Usha Govindarajulu, Emilia Bagiella, Ruchir Goswami, Minal Kale, Kirk N. Campbell, Kristin Meliambro, Zijian Chen, Judith A. Aberg, and Jenny J. Lin. “Association of Vaccination with the Persistence of Post-COVID Symptoms.” Journal of General Internal Medicine, March 9, 2022.

6c. Research

RECOVER: Researching COVID to Enhance Recovery. “RECOVER: Researching COVID to Enhance Recovery.” Accessed April 15, 2022.
6c1. Funding Research
Archewell | Shared Purpose. Global Action.
Focus: Fogarty awards $3.3M in COVID-19 supplements to support research, training - Fogarty International Center @ NIH
Fogarty's Role in Global Health - Fogarty International Center @ NIH NOT-TW-21-004: Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries NOT-TW-21-003: Notice of Special Interest (NOSI): Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards
COVID-19 Research Project Tracker by UKCDR & GloPID-R | UKCDR
UKCDR-0704-Tracker-Highlights-Long-Covid.pdf Opportunities – UKRI Who we fund – UKRI A Coordinated Global Research Roadmap
<<< Return to the May 20 - Actual Questions 
<<< Home


0 Poster un commentaire

A découvrir aussi